EUVIMEDEUVIMED entdecken
Crossref

First‐trimester pre‐eclampsia screening and adverse pregnancy outcomes beyond pre‐eclampsia

Linus L T Lee iD, Suet Yin Ho, Lin Wai Chan iD

International Journal of Gynecology & Obstetrics · 2026

DOI: 10.1002/ijgo.70995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Linus L T Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong. Hauptthemen laut MEDLINE: Pre-Eclampsia, Pregnancy Outcome, Premature Birth. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine if those screened as high‐risk for preterm pre‐eclampsia at first‐trimester Fetal Medicine Foundation (FMF)‐based screening and given aspirin are at higher risk of adverse pregnancy outcomes, even after adjusting for pre‐eclampsia.

Methods

This retrospective cohort study included 1623 ethnically Chinese women who received FMF‐based pre‐eclampsia screening, and subsequently delivered within our hospital system. Pregnancy outcomes were compared between screen‐positives (high risk, given aspirin) and screen‐negatives, and adjusted by pre‐eclampsia status and any hypertension in pregnancy.

Results

After adjustment for pre‐eclampsia, screen‐positives still delivered earlier (−0.7 weeks, P < 0.001), with a higher rate of preterm birth (PTB) before 37 weeks (odds ratio [OR] 2.413, P = 0.002). Birth weight centiles in the screen‐positive group were lower (−8.3, P = 0.001), with small‐for‐gestational‐age (SGA) being more common in the screen‐positive group (OR 2.697, P < 0.001). Emergency cesarean was more common (OR 2.943, P < 0.001), rate of admission to neonatal intensive care unit was higher (OR 2.044, P = 0.014), and stillbirths were more common (OR 5.131, P = 0.038).

Conclusion

The risks for SGA/fetal growth restriction and PTB were significantly higher in those who screened positive at FMF first‐trimester pre‐eclampsia screening, even after adjusting for pre‐eclampsia, and they may benefit from increased surveillance. Components of FMF‐based first‐trimester pre‐eclampsia screening overlap substantially with uteroplacental great obstetrical syndromes, and help to identify a broader placental‐risk phenotype. Future research may explore how this information could be further operationalized—through refinement of risk thresholds and incorporation of adjunctive strategies. Nevertheless, the lack of highly effective strategies to further stratify and prevent SGA/fetal growth restriction and spontaneous PTB remains a challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPregnancy OutcomePremature BirthHumansFemalePregnancyPregnancy Trimester, FirstRetrospective StudiesAdultInfant, NewbornInfant, Small for Gestational AgeAspirinBirth WeightChinaCesarean SectionRisk FactorsMass Screening

Stichwörter der Autor:innen

Fetal Medicine Foundation screeningfirst‐trimester screeningplacental biomarkerspregnancy outcomepremature birthpre‐eclampsia

Substanzen

Aspirin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong.

ORCID-Profile: Linus L T Lee, Lin Wai Chan

Zitieren

APA

Lee, L. L. T., Ho, S. Y., & Chan, L. W. (2026). First‐trimester pre‐eclampsia screening and adverse pregnancy outcomes beyond pre‐eclampsia. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70995

Vancouver

Lee LLT, Ho SY, Chan LW. First‐trimester pre‐eclampsia screening and adverse pregnancy outcomes beyond pre‐eclampsia. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.70995

BibTeX
@article{Lee2026,
  author = {Lee, Linus L T and Ho, Suet Yin and Chan, Lin Wai},
  title = {First‐trimester pre‐eclampsia screening and adverse pregnancy outcomes beyond pre‐eclampsia},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  doi = {10.1002/ijgo.70995}
}
Kostenlos starten →